Whether the Role of Esophageal Baseline Impedance Is Complementary to or Alternative to the 24-Hour Esophageal pH Monitoring for the Diagnosis of Gastroesophageal Reflux Disease?
Abstract
c 2020 The Korean Society of Neurogastroenterology and Motility J Neurogastroenterol Motil, Vol. 26 No. 4 October, 2020 www.jnmjournal.org Ambulatory reflux monitoring assesses reflux burden using acid exposure time and reflux-symptom association. Chronic esophageal acid exposure in the animal and human models induces changes in the mucosa, seen histologically by increased numbers of dilated intracellular spaces. Low baseline impedance (BI) in the distal esophagus is likely explained by reflux-mediated damage to the integrity of esophageal mucosa. Esophageal BI has been suggested as a surrogate marker for esophageal mucosal integrity which may reflect longitudinal reflux mucosal injury over time. Distal esophageal mucosal BI measured during the ambulatory 24-hour esophageal pH-impedance monitoring is considered to be a surrogated market of reflux burden. Esophageal BI values can be acquired via several approaches; (1) from nocturnal periods without swallows during ambulatory pH-impedance tracings as mean nocturnal baseline impedance (MNBI), (2) from prototype balloon-mounted electrodes during sedated endoscopy (mucosal integrity or mucosal impedance [MI]), or (3) from high-resolution impedance manometry (HRIM) studies during the resting landmark phase prior to administration of test swallows (BI-HRIM). MNBI, BI-HRIM, and MI are all considered adjunctive metrics supporting a gastroesophageal reflux disease (GERD) diagnosis. MNBI may be of particular value when acid exposure…
Read the paper
Related studies
- Advantages and Disadvantages of Long-term Proton Pump Inhibitor Use
- Ivth brazilian consensus conference on helicobacter pylori infection
- A pSMAD/CDX2 complex is essential for the intestinalization of epithelial metaplasia
- S2k-Leitlinie Gastroösophageale Refluxkrankheit und eosinophile Ösophagitis der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – März 2023 – AWMF-Registernummer: 021–013
- Step-by-step management of refractory gastresophageal reflux disease
- Insights into Effects/Risks of Chronic Hypergastrinemia and Lifelong PPI Treatment in Man Based on Studies of Patients with Zollinger–Ellison Syndrome
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.